Results 131 to 140 of about 1,946,462 (288)

A DOSE OF YOUR OWN MEDICINE? DRUG TESTING ON CHILDREN AND LABELING DRUGS FOR PEDIATRIC USE--ESSENTIAL NEEDS [PDF]

open access: yes, 2012
Children are not just miniature adults; a child metabolizes and absorbs drugs differently than adults, making drug testing and labeling regarding pediatric use essential. This paper first addresses these needs in more detail.
Gendell, Stephanie J.
core  

Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology

open access: yesMolecular Oncology, EarlyView.
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts   +8 more
wiley   +1 more source

Assistência farmacêutica na atenção básica de saúde: a experiência de três estados brasileiros

open access: yesCadernos de Saúde Pública
No contexto das mudanças ocorridas no sistema de fornecimento de medicamentos em nível nacional no Brasil, com destaque para a desativação da Central de Medicamentos (CEME), e da crescente descentralização das ações de saúde no âmbito do Sistema Único de
Marly Aparecida Elias Cosendey   +5 more
doaj  

Abastecimiento de medicamentos en unidades de primer nivel de atención de la Secretaría de Salud de México Drug supplies at Ministry of Health primary health care units in Mexico

open access: yesSalud Pública de México, 2001
Objetivo. Conocer el nivel de disponibilidad de algunos medicamentos esenciales (ME) en las unidades de primer nivel de atención de la Secretaría de Salud de México (SSA), a partir de una investigación realizada en 1996-1997. Material y métodos.
Octavio Gómez-Dantés   +4 more
doaj  

Drug Management Reviews in District Drug Management Unit and General Hospital [PDF]

open access: yes, 2009
Drug is one of the essential elements in healthcare that should be effectively and efficiently managed. Following the decentralization in 2001 in Indonesia, drug management has changed in district drug management units and also in District General ...
Handayani, R. S. (Rini)   +2 more
core  

Adenosine‐to‐inosine editing of miR‐200b‐3p is associated with the progression of high‐grade serous ovarian cancer

open access: yesMolecular Oncology, EarlyView.
A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira   +14 more
wiley   +1 more source

Investigating the cell of origin and novel molecular targets in Merkel cell carcinoma: a historic misnomer

open access: yesMolecular Oncology, EarlyView.
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian   +10 more
wiley   +1 more source

Sobreprecio y acceso a los medicamentos: el caso de los medicamentos esenciales en México

open access: yesCadernos de Saúde Pública
Para la Organización Mundial de la Salud (OMS) la accesibilidad y la disponibilidad de los medicamentos es un tema central al cual le ha dedicado una gran atención.
Raúl E. Molina-Salazar   +1 more
doaj  

Integrated genomic and proteomic profiling reveals insights into chemoradiation resistance in cervical cancer

open access: yesMolecular Oncology, EarlyView.
A comprehensive genomic and proteomic analysis of cervical cancer revealed STK11 and STX3 as a potential biomarkers of chemoradiation resistance. Our study demonstrated EGFR as a therapeutic target, paving the way for precision strategies to overcome treatment failure and the DNA repair pathway as a critical mechanism of resistance.
Janani Sambath   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy